AlzChem Group Balance Sheet Health
Financial Health criteria checks 6/6
AlzChem Group has a total shareholder equity of €182.6M and total debt of €53.6M, which brings its debt-to-equity ratio to 29.3%. Its total assets and total liabilities are €463.4M and €280.9M respectively. AlzChem Group's EBIT is €66.8M making its interest coverage ratio 26.4. It has cash and short-term investments of €46.1M.
Key information
29.3%
Debt to equity ratio
€53.55m
Debt
| Interest coverage ratio | 26.4x |
| Cash | €46.07m |
| Equity | €182.55m |
| Total liabilities | €280.87m |
| Total assets | €463.43m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ACTD's short term assets (€255.9M) exceed its short term liabilities (€109.9M).
Long Term Liabilities: ACTD's short term assets (€255.9M) exceed its long term liabilities (€170.9M).
Debt to Equity History and Analysis
Debt Level: ACTD's net debt to equity ratio (4.1%) is considered satisfactory.
Reducing Debt: ACTD's debt to equity ratio has reduced from 150.7% to 29.3% over the past 5 years.
Debt Coverage: ACTD's debt is well covered by operating cash flow (180.5%).
Interest Coverage: ACTD's interest payments on its debt are well covered by EBIT (26.4x coverage).